2024.04.30InFlectis BioScience, a portfolio company of Remiges Ventures in France, was awarded a grant from the National Multiple Sclerosis Society to advance IFB-048 preclinical development in multiple sclerosis. The research will be performed by Prof. Brian Popko of Northwestern University